SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 4/30/2012 | 1/31/2012 | 10/31/2011 | |
|---|---|---|---|---|
| Revenue | -$6 | $16 | $28 | $75 |
| % Growth | -134.6% | -42.6% | -63% | – |
| Cost of Goods Sold | $7 | $6 | $22 | $39 |
| Gross Profit | -$13 | $10 | $6 | $36 |
| % Margin | 231.2% | 63.5% | 21.2% | 47.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $128 | $62 | $156 | $1,775 |
| SG&A Expenses | $128 | $62 | $156 | $1,775 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $128 | $62 | $156 | $1,775 |
| Operating Income | -$141 | -$52 | -$150 | -$1,739 |
| % Margin | 2,541.4% | -324.6% | -539.6% | -2,310.2% |
| Other Income/Exp. Net | $141 | $52 | $150 | $1,739 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$255 | -$173 | -$510 | -$1,801 |
| % Margin | 4,597.8% | -1,078.2% | -1,827.9% | -2,392.3% |
| EPS | -0 | -0 | -0 | -0.01 |
| % Growth | -47.5% | 67.7% | 99% | – |
| EPS Diluted | -0 | -0 | -0 | -0.01 |
| Weighted Avg Shares Out | 5,346,848 | 5,346,848 | 5,818,132 | 4,994,340 |
| Weighted Avg Shares Out Dil | 5,346,848 | 5,346,848 | 5,818,132 | 4,994,340 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $72 | $70 | $58 | $77 |
| Depreciation & Amortization | -$13 | $5 | $3 | $6 |
| EBITDA | -$520 | -$47 | -$147 | -$1,733 |
| % Margin | 9,387.7% | -296.1% | -527.4% | -2,302.4% |